Early versus late treatment of spinal cord compression with long-term intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type I
Keywords: نمایندگان مجلس; IT; intrathecal; IV; intravenous; MPS; mucopolysaccharidosis; rhIDU; recombinant human alpha-l-iduronidase; GAG; glycosaminoglycans; ERT; enzyme replacement therapy; Mucopolysaccharidosis; Hurler; Intrathecal; Enzyme replacement therapy; Lysosomal storage